Bio Green Med Solution, Inc. — Director's Dealing 2025

Sep 2, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2025-09-01

Reporting Person: Yap Kim Choy (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	218000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Common Stock Warrants	$7.65	2030-06-20	Common Stock (218000)		Direct
Series B Common Stock Warrants	$9.00	2030-06-20	Common Stock (218000)		Direct
Series C Common Stock Warrants	$10.20	2030-06-20	Common Stock (218000)		Direct

Footnotes

F1: In connection with a securities purchase agreement dated June 20, 2025, Mr. Yap acquired 218,000 shares of the Company's common stock. He also received series A, series B and series C common stock purchase warrants to each purchase 218,000 shares of the Company's common stock, respectively. The beneficial ownership limitation of 4.99% under each such warrant was removed on September 1, 2025